Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire Dijon
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who have provided oral consent
Patients older than 18
Patients with type 1 or 2 diabetes
Patients who can be followed-up in the context of consultations for diabetic foot at the endocrinology, diabetology and metabolic diseases unit of Dijon CHU.
Lesion situated on a toe or on the plantar or dorsal side of the foot
Lesion that has evolved for 1 to 24 months
You may not be if
Adult under guardianship
Patient without national health insurance
Pregnant or breast-feeding women
Patients with progressive cancer
Patients with terminal renal insufficiency on dialysis
Patient with severe respiratory insufficiency
Patients with terminal heart failure
Patients with severe liver failure
Patients with immunodepriession (treatement with immunosuppressants, long-term corticotherapy, diseases leading to immunodepression)
Patients with nephrotic syndrome (hypoalbuminemia)
Patientswith a chronic inflammatory syndrome
Alcohol consumption greater than 4 glasses per day
Systemic infection uncontrolled by antibiotics
Infected lesion with systemic repercussions
Charcot foot
Patients taking part or who have planned to take part in another clinical trial
Severe disease affecting survival in the short term
